[Ulcerative colitis in children. Levels of salicylazosulfapyridine and sulfapyridine during treatment].

Salicylazosulfapyridine (SASP) is a drug used in the treatment of ulcerative colitis (UC) owing to the therapeutic action of the 5-aminosalicylic acid produced by the splitting of the molecule in the cecum, which also yields the absorbable compound Sulphapyridine (SP). The aim of our work was to assess the levels of the drug in blood (SASP and SP), to correlate them with undesirable effects in any, to verify their fluctuations in the dosing interval and to investigate the extent of the excretion of the drug in the children who were studied. 10 children (6 to 16 years) with UC, who were treated with SASP (dOsage schedule 0.

[Determination of amylase creatinine clearance in children and adolescents].

Unlabelled: 24 children whose ages ranged from 10 days to 14 years (x 5.5. ys.

[Prolonged diarrhea in infancy: effect of deconjugated bile acids and cholestyramine action].

527 patients whose ages ranged from 3 months to 5 years, with acute diarrhea were studied. 517 showed satisfactory response to treatment. Diarrhea persisted in 10 patients (2 %) and bile acids were determined in intestinal juice before and after cholestyramine administration.